Newsletter - July 2021

real-world evidence in action

Featured Content

real-world evidence in action

Real-World Evidence in Action

Via DHC →
The DHC is currently conducting a project to evaluate innovative applications and future opportunities of real-world evidence in the pharmaceutical industry, specifically within sales and marketing. The objective is to collect insights into how organizations are leveraging RWE in actionable ways that can be measured. The project includes numerous interviews with RWE experts within the pharmaceutical space and will conclude with a POV to be released soon, but we wanted to share some early insights in this summary.

Read Summary →

DHC Partner Insights

Real-World Case Study: Leveraging Real-World Evidence to Drive Physician Engagement

Via Sermo →
Check out this recent RWE campaign on Sermo that had near universal recall and effectively increased message recall among targeted physicians, signaling this is an extremely effective content strategy for educating HCPs and supporting their treatment decision-making.

Read More →

Oral Health Brand

CMI Media Group Delivers Sweet Results For Oral Health Brand

Via CMI Media Group →
Build it - and results will come. CMI Media Group and Microsoft partnered to bring an industry-first to a pharma client looking to expand sales of its over-the-counter oral healthcare brand and reach more consumers in a cost-efficient manner. The partners piloted HCP targeting in the Microsoft Audience Network — a truly visionary idea, given that this was a capability that had not yet been added to the platform. The results: more than 20 million impressions, 127,811 clicks, and 2,401 conversions, yielding an impressive $13.25 CPA, which is 24% lower than their CPA benchmark.

Read More →

Evidence-Based Physician Engagement

OptimizeRx to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients

Via OptimizeRx →
OptimizeRx’s AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans. This month, OptimizeRx has announced that it has signed an agreement with one of the top 5 pharmaceutical companies to drive a new patient affordability initiative. The OptimizeRx platform will leverage RWE to provide visibility to doctors when Medicare patients’ treatment plans are at risk of lapse due to loss of coverage.

Read More →

Get Involved

Live Webinars
PMA Webinars - Applications in Advanced Analytics to Increase Early Treatment Rates in Patients with Multiple Sclerosis

Applications in Advanced Analytics to Increase Early Treatment Rates in Patients with Multiple Sclerosis

HOSTED BY: OptimizeRx
WHEN: September 15, 2021 | 1PM ET

Understanding key factors that delay new patient starts on therapy are critical to reaching and educating patients and getting them on the right therapy early on to prevent disease progression and keeping them adherent to prevent disability.

Register Now →

Surveys
Pharma Marketers Respond to Agile Operations -Tell us what you think

RWE for Sales and Marketing - Seeking Expert POVs

Via OptimizeRX →
The DHC has partnered with OptimizeRx to evaluate innovative applications and future opportunities of real-world evidence in the pharmaceutical industry, specifically within sales and marketing. The objective is to collect insights into how organizations are leveraging RWE in actionable ways that can be measured.

Take Survey →

WEGO Health Judge Search

WEGO Health Industry Award Nominations

Via WEGO Health →
Calling all media agency and pharma company employees: Want a way to underscore your company and brand's commitment to patients? Sign up to be a WEGO Health Awards judge! Judging is a small time commitment with a big-time impact on your brand reputation, and it feels incredible to give back in a big way to the patient communities you serve. As a judge, you'll help us determine the patient winners of the WEGO Health Awards: the world's leading patient leaders!

Sign Up Now →

Events
Improving Health Equity Through Cross-Cultural Marketing: Pharma Thought Leaders Discuss

Improving Health Equity Through Cross-Cultural Marketing: Pharma Thought Leaders Discuss

DATE: August 19, 2021
TIME: 1PM ET

Hear from leaders in cross-cultural marketing on how to create a business case internally and collaborate successfully externally. Experts will provide insights on the importance of language and its nuances. Gain new vocabulary and language for essential conversations around cross-cultural marketing and its ability to advance inclusivity and better health outcomes.

Register Now →

dhc virtual summit series

DHC Virtual Summit Hosted with Otsuka

DATE: September 9-10, 2021
TIME: 12PM - 1:30PM ET

Join fellow colleagues and pharmaceutical marketers, researchers, and thought leaders for a virtual innovation Summit hosted by the Digital Health Coalition (DHC) and Otsuka. The September 9th & 10th virtual event will focus on Addressing Health Access, Inequity, and Inclusion Through Digital and The Future of Digital Medicine. Register now to hold your seat.

Register Now →

DHC Content

On-Demand Webinars
Customer Experiences in Life Sciences

Customer Experience in Life Sciences

Rich Schwartz of Medallia and Mark Bard of the DHC Group share research findings from both HCPs and marketers taking a look at the current role of customer experience in life sciences. They were joined by Laurie Meyers, Sr. Director, Experience and Engagement Design at Genentech and Jessica Saperstein, Head of Customer Experience and Consumer Marketing at Novartis to further discuss and apply these insights to the future of CX in our industry.

Watch Webinar →

Subscribe to Newsletter

Receive more DHC content like this directly in your inbox. We will respect your privacy and never sell your information. View our Privacy Policy.

* indicates required
 
 
Menu